Cicero, Calogero Edoardo
Chisari, Clara
Salafica, Giuseppe
Lo Fermo, Salvatore
Donzuso, Giulia
Maimone, Davide
Marziolo, Roberto
Patti, Francesco
Nicoletti, Alessandra
Article History
Received: 11 October 2024
Accepted: 25 November 2024
First Online: 28 November 2024
Declarations
:
: CEC reports no conflict of interest with respect to the research, authorship and publication of this article.CC has received grants for congress participation from Almirall, Biogen, Merck Serono, Novartis, Roche, Sanofi Genzyme, and TEVA.GS reports no conflict of interest with respect to the research, authorship and publication of this article.SLF reports no conflict of interest with respect to the research, authorship and publication of this article.GD reports no conflict of interest with respect to the research, authorship and publication of this article.DM reports no conflict of interest with respect to the research, authorship and publication of this article.RM reports no conflict of interest with respect to the research, authorship and publication of this article.FP has received honoraria for speaking activities by Almirall, Bayer, Biogen, Merck Serono, Novartis, Roche, Sanofi Genzyme, and TEVA; he also served as advisory board member the following companies: Bayer, Biogen, Merck Serono, Novartis, Roche, Sanofi Genzyme, Alexion, and TEVA; he was also funded by Pfizer and FISM for epidemiological studies; he received grants for congress participation from Almirall, Bayer, Biogen, Merck Serono, Novartis, Roche, Sanofi Genzyme, and TEVA. AN reports no conflict of interest with respect to the research, authorship and publication of this article.